Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
P53 and Sirt1: routes of metabolism and genome stability.
Gonfloni S, Iannizzotto V, Maiani E, Bellusci G, Ciccone S, Diederich M. Gonfloni S, et al. Among authors: iannizzotto v. Biochem Pharmacol. 2014 Nov 1;92(1):149-56. doi: 10.1016/j.bcp.2014.08.034. Epub 2014 Sep 9. Biochem Pharmacol. 2014. PMID: 25218422 Review.
P63 in health and cancer.
Gonfloni S, Caputo V, Iannizzotto V. Gonfloni S, et al. Among authors: iannizzotto v. Int J Dev Biol. 2015;59(1-3):87-93. doi: 10.1387/ijdb.150045sg. Int J Dev Biol. 2015. PMID: 26374530 Free article. Review.
Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome.
Nayar S, Campos J, Smith CG, Iannizzotto V, Gardner DH, Colafrancesco S, Pipi E, Kollert F, Hunter KJ, Brewer C, Buckley CD, Bowman SJ, Priori R, Valesini G, Juarez M, Fahy WA, Fisher BA, Payne A, Allen RA, Barone F. Nayar S, et al. Among authors: iannizzotto v. Ann Rheum Dis. 2019 Feb;78(2):249-260. doi: 10.1136/annrheumdis-2017-212619. Epub 2018 Nov 24. Ann Rheum Dis. 2019. PMID: 30472652 Free PMC article.
CXCL13 as biomarker for histological involvement in Sjögren's syndrome.
Colafrancesco S, Priori R, Smith CG, Minniti A, Iannizzotto V, Pipi E, Lucchesi D, Pontarini E, Nayar S, Campos J, Arienzo F, Fusconi M, Cerbelli B, Giordano C, Valesini G, Bombardieri M, Fisher BA, Barone F. Colafrancesco S, et al. Among authors: iannizzotto v. Rheumatology (Oxford). 2020 Jan 1;59(1):165-170. doi: 10.1093/rheumatology/kez255. Rheumatology (Oxford). 2020. PMID: 31274159
Autophagy occurs in lymphocytes infiltrating Sjögren's syndrome minor salivary glands and correlates with histological severity of salivary gland lesions.
Colafrancesco S, Vomero M, Iannizzotto V, Minniti A, Barbati C, Arienzo F, Mastromanno L, Colasanti T, Izzo R, Nayar S, Pipi E, Cerbelli B, Giordano C, Ciccia F, Conti F, Valesini G, Barone F, Priori R, Alessandri C. Colafrancesco S, et al. Among authors: iannizzotto v. Arthritis Res Ther. 2020 Oct 13;22(1):238. doi: 10.1186/s13075-020-02317-6. Arthritis Res Ther. 2020. PMID: 33050949 Free PMC article.
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.
Nayar S, Campos J, Smith CG, Iannizzotto V, Gardner DH, Mourcin F, Roulois D, Turner J, Sylvestre M, Asam S, Glaysher B, Bowman SJ, Fearon DT, Filer A, Tarte K, Luther SA, Fisher BA, Buckley CD, Coles MC, Barone F. Nayar S, et al. Among authors: iannizzotto v. Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13490-13497. doi: 10.1073/pnas.1905301116. Epub 2019 Jun 18. Proc Natl Acad Sci U S A. 2019. PMID: 31213547 Free PMC article.
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction.
Nayar S, Pontarini E, Campos J, Berardicurti O, Smith CG, Asam S, Gardner DH, Colafrancesco S, Lucchesi D, Coleby R, Chung MM, Iannizzotto V, Hunter K, Bowman SJ, Carlesso G, Herbst R, McGettrick HM, Browning J, Buckley CD, Fisher BA, Bombardieri M, Barone F. Nayar S, et al. Among authors: iannizzotto v. Commun Biol. 2022 May 4;5(1):413. doi: 10.1038/s42003-022-03344-6. Commun Biol. 2022. PMID: 35508704 Free PMC article.
Leflunomide-hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial.
van der Heijden EHM, Blokland SLM, Hillen MR, Lopes APP, van Vliet-Moret FM, Rosenberg AJWP, Janssen NG, Welsing PMJ, Iannizzotto V, Tao W, Pandit A, Barone F, Kruize AA, Radstake TRDJ, van Roon JAG. van der Heijden EHM, et al. Among authors: iannizzotto v. Lancet Rheumatol. 2020 May;2(5):e260-e269. doi: 10.1016/S2665-9913(20)30057-6. Epub 2020 Mar 26. Lancet Rheumatol. 2020. PMID: 38273473